Unchecked |
Inhibition |
= |
-5.924 |
% |
Human HepG2 cell viability assay in 384 well format |
CHEMBL3507680 |
Schistosoma mansoni |
Inhibition |
= |
8.92 |
% |
In vitro activity on S. mansoni schistosomula at 50 uM |
CHEMBL3988442 |
Plasmodium berghei |
INHIBITION |
= |
-5.2 |
% |
Screen against P. berghei liver stage (PbLuc), transformed with Luciferase, at 2uM |
CHEMBL4513216 |
Plasmodium berghei |
INHIBITION |
= |
27.9 |
% |
Screen against P. berghei liver stage (PbLuc), transformed with Luciferase, at 10uM |
CHEMBL4513216 |
HepG2 |
INHIBITION |
= |
-10.9 |
% |
Toxicity liver stage against HepG2, at 10uM |
CHEMBL4513216 |
Plasmodium falciparum |
INHIBITION |
= |
-77.2 |
% |
Screen against P. falciparum Asexual Blood Stage (ABS), at 5uM |
CHEMBL4513216 |
Plasmodium falciparum |
INHIBITION |
= |
1.15 |
% |
Screen against P. falciparum Stg V gametocytes, at 2uM |
CHEMBL4513216 |
Coenzyme A biosynthesis bifunctional protein CoaBC |
Percent Effect |
= |
1.7990000000000002 |
% |
Biomol Green assay for MtCoaBC inhibitor, OD650 read |
CHEMBL3988442 |
Unchecked |
Percent Effect |
= |
1.605 |
% |
Trypanosoma cruzi phosphomannomutase and mannose-1-phosphate guanylyltransferase assay |
CHEMBL3988442 |
Trypanosoma brucei |
Percent Effect |
= |
-7.086 |
% |
Trypanosoma brucei 72 hour study |
CHEMBL3988442 |
Chromo domain-containing protein 1 |
Percent Effect |
= |
-7.192 |
% |
ScCHD-1 Enzyme Inhibition Assay |
CHEMBL3988442 |
ClpP1P2 |
Percent Effect |
= |
-1.75 |
% |
in vitro assay to detect presence of AMC directly proportional to the activity of ClpP1P2. GHDDI collaboration. |
CHEMBL3988442 |
Plasmodium falciparum |
Percent Effect |
= |
5.181 |
% |
Plasmodium falciparum sporozoite viability assay |
CHEMBL3988442 |
Wolbachia pipientis |
Percent Effect |
= |
-7.398 |
% |
Anti-Wolbachia Cell-Based Screen |
CHEMBL3988442 |
Polyketide synthase Pks13 |
Percent Effect |
= |
-26.87 |
% |
Mycobacterium tuberculosis Polyketide synthase 13 Thioesterase (PKS13) |
CHEMBL3988442 |
Unchecked |
Percent Effect |
= |
-23.55 |
% |
Phenotypic growth assay for Mycobacterium tuberculosis grown for 4 days on DPPC, cholesterol, tyloxapol based media |
CHEMBL3988442 |
Trypanosoma cruzi |
Percent Effect |
= |
-122.15 |
% |
T. cruzi routine single point assay with increased parasite load to give indication of cidality of compounds (rank compounds by MAX Percent Inhibition) |
CHEMBL3988442 |
Mycobacterium tuberculosis |
Percent Effect |
= |
16.77 |
% |
Cornell M. t heat shock assay |
CHEMBL3988442 |
Trypanosoma cruzi |
Percent Effect |
= |
-129.52 |
% |
T. cruzi routine single point assay with increased parasite load to give indication of cidality of compounds (rank compounds by MAX Percent Inhibition) |
CHEMBL3988442 |
Arginase-2, mitochondrial |
Percent Effect |
= |
6.464 |
% |
in vitro enzyme assay to detect the production of urea directly proportional to the activity of Arginase II |
CHEMBL3988442 |
Mycobacterium tuberculosis |
Percent Effect |
= |
15.17 |
% |
Cornell - Phenotypic assay to identify agents that inhibit growth of Mycobacterium tuberculosis |
CHEMBL3988442 |
Histidine--tRNA ligase |
Percent Effect |
= |
-19.1 |
% |
Leishmania infantum Histidine tRNA synthetase (LdHisRS) |
CHEMBL3988442 |
Histidine--tRNA ligase |
Percent Effect |
= |
2.256 |
% |
Trypanosoma cruzi histidyl tRNA synthetase (Tc-HisRS) |
CHEMBL3988442 |
Ubiquitin-activating enzyme e1, putative |
Percent Effect |
= |
17.72 |
% |
Leishmania donovani Ubiquitin Activating Enzyme (LdE1) |
CHEMBL3988442 |
Trypanosoma cruzi |
Percent Effect |
= |
-137.44 |
% |
T. cruzi routine single point assay with increased parasite load to give indication of cidality of compounds (rank compounds by MAX Percent Inhibition) |
CHEMBL3988442 |
Tryptophan--tRNA ligase |
Percent Effect |
= |
4.642 |
% |
Biochemical assay for Mt-TrpRS |
CHEMBL3988442 |
Plasmodium falciparum |
Percent Effect |
= |
-82.45 |
% |
Calibr Malaria Delayed Death Assay SOP |
CHEMBL3988442 |
Shiga toxin 2 |
Percent Effect |
= |
-8.407 |
% |
E. coli 0.157:H7 Shiga Toxin SOP - stx2 screening assay |
CHEMBL3988442 |
AMP-activated protein kinase, AMPK |
Percent Effect |
= |
-12.88 |
% |
AMP-dependent Kinase enzyme assay. An in vitro enzyme assay that detects ADP turnover that is directly proportional to AMPK activity. This uses naive AMPK that is activated during the assay with MK-8722 |
CHEMBL3988442 |
Sialic acid-binding Ig-like lectin 9 |
Percent Effect |
= |
-5.836 |
% |
Hs-Siglec9 ALPHAscreen SOP 20170721 |
CHEMBL3988442 |
Tyrosyl-tRNA synthetase, putative |
Percent Effect |
= |
5.419 |
% |
Trypanosoma cruzi tyrosyl tRNA synthetase (TcYRS) _High Tyrosine SOP |
CHEMBL3988442 |
Tyrosyl-tRNA synthetase, putative |
Percent Effect |
= |
13.92 |
% |
Trypanosoma cruzi tyrosyl tRNA synthetase (TcYRS) SOP |
CHEMBL3988442 |
Proteasome subunit beta |
Percent Effect |
= |
4.013 |
% |
Trypanosoma cruzi proteasome chymotrypsin-like activity (TcProtChymo) assay. |
CHEMBL3988442 |
Leishmania donovani |
Percent Effect |
= |
31.88 |
% |
Leishmania intramacrophage assay |
CHEMBL3988442 |
Protein translocase subunit SecA |
Percent Effect |
= |
-4.862 |
% |
Assay to Identify E. coli SecA ATPase Inhibitors |
CHEMBL3988442 |
Lysine--tRNA ligase |
Percent Effect |
= |
7.1229999999999976 |
% |
Pf-KRS-1 (Lysyl-RNA Synthetase-1, KRS-1, cytosolic KRS) from Plasmodium falciparum. Inhibitor assay, 384 well plate, luminescence read. |
CHEMBL3988442 |
Aspartate--tRNA(Asp/Asn) ligase |
Percent Effect |
= |
-5.9110000000000005 |
% |
Assay for Asp RNA synthetase-1 from Mycobacterium tuberculosis |
CHEMBL3988442 |
Unchecked |
Percent Effect |
= |
-25.25 |
% |
Phenotypic growth assay for Mycobacterium tuberculosis grown for 3 days on 7H9, glucose tyloxapol based media |
CHEMBL3988442 |
Unchecked |
Percent Effect |
= |
-3.5580000000000003 |
% |
To identify inhibition of the IFN signalling (Jak-Stat) pathway via expression of an eGFP reporter gene under the control of an IFN-stimulated response element (ISRE) containing MxA promoter. |
CHEMBL3988442 |
Trypanosoma cruzi |
Percent Effect |
= |
-98.09 |
% |
T. cruzi routine single point assay with increased parasite load to give indication of cidality of compounds (rank compounds by MAX Percent Inhibition) |
CHEMBL3988442 |